These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17468923)

  • 21. Technical problems produced by the Bravo pH test in nonerosive reflux disease patients.
    de Hoyos A; Esparza EA
    World J Gastroenterol; 2010 Jul; 16(25):3183-6. PubMed ID: 20593504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Esophageal pH monitoring with the BRAVO capsule: experience in a single tertiary medical center.
    Cabrera J; Davis M; Horn D; Pfefferkorn M; Croffie JM
    J Pediatr Gastroenterol Nutr; 2011 Oct; 53(4):404-8. PubMed ID: 21519281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use and utility of the Bravo pH capsule.
    Pandolfino JE; Kwiatek MA
    J Clin Gastroenterol; 2008; 42(5):571-8. PubMed ID: 18364590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
    Schey R; Alla SP; Midani D; Parkman HP
    Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wireless esophageal pH monitoring: new technique means new questions.
    Bhat YM; McGrath KM; Bielefeldt K
    J Clin Gastroenterol; 2006 Feb; 40(2):116-21. PubMed ID: 16394871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and tolerability of transoral Bravo capsule placement after transnasal manometry using a validated conversion factor.
    Lacy BE; O'Shana T; Hynes M; Kelley ML; Weiss JE; Paquette L; Rothstein RI
    Am J Gastroenterol; 2007 Jan; 102(1):24-32. PubMed ID: 17100980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The Additional Role of Symptom-Reflux Association Analysis of Diagnosis of Gastroesophageal Reflux Disease Using Bravo Capsule pH Test].
    Jung K; Park MI; Park SJ; Moon W; Kim SE; Kim JH
    Korean J Gastroenterol; 2017 Oct; 70(4):169-175. PubMed ID: 29060954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accuracy and tolerability of the Bravo catheter-free pH capsule in patients between the ages of 4 and 18 years.
    Croffie JM; Fitzgerald JF; Molleston JP; Gupta SK; Corkins MR; Pfefferkorn MD; Lim JR; Steiner SJ; Dadzie SK
    J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):559-63. PubMed ID: 18030233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bravo capsule induction of esophageal hypercontractility and chest pain.
    Tharavej C; Hagen JA; Portale G; Hsieh CC; Gandamihardja TA; Lipham JC; Peters JH; DeMeester SR; Crookes PF; Bremner CG; DeMeester TR
    Surg Endosc; 2006 May; 20(5):783-6. PubMed ID: 16544080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Forty-eight-hour pH monitoring increases sensitivity in detecting abnormal esophageal acid exposure.
    Tseng D; Rizvi AZ; Fennerty MB; Jobe BA; Diggs BS; Sheppard BC; Gross SC; Swanstrom LL; White NB; Aye RW; Hunter JG
    J Gastrointest Surg; 2005 Nov; 9(8):1043-51; discussion 1051-2. PubMed ID: 16269374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review article: oesophageal pH monitoring--technologies, interpretation and correlation with clinical outcomes.
    Kahrilas PJ; Pandolfino JE
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():2-9. PubMed ID: 16303031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two years' experience of using the Bravo wireless oesophageal pH monitoring system at a single UK tertiary centre.
    Rao NM; Campbell DI; Rao P
    Acta Paediatr; 2017 Feb; 106(2):312-315. PubMed ID: 27862298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of wireless 48-h (Bravo) versus traditional ambulatory 24-h esophageal pH monitoring.
    Håkanson BS; Berggren P; Granqvist S; Ljungqvist O; Thorell A
    Scand J Gastroenterol; 2009; 44(3):276-83. PubMed ID: 19040176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sedation and Afternoon Placement of the 48-Hour Wireless Ambulatory pH Capsule Results in More Reflux on the First Day.
    Patel R; Chae S; Kumar A; Richter JE
    J Clin Gastroenterol; 2017 Aug; 51(7):594-598. PubMed ID: 27548735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does the Bravo pH capsule affect esophageal motor function?
    Pandolfino JE; Zhang Q; Ghosh SK; Roth MP; Boniquit C; Kahrilas PJ
    Dis Esophagus; 2007; 20(5):406-10. PubMed ID: 17760654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wireless ambulatory pH studies: manometric or endoscopic guidance?
    Nusrat S; Roy PM; Bielefeldt K
    Dis Esophagus; 2012 Jan; 25(1):26-32. PubMed ID: 21676068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous laryngopharyngeal pH monitoring (Restech) and conventional esophageal pH monitoring-correlation using a large patient cohort of more than 100 patients with suspected gastroesophageal reflux disease.
    Fuchs HF; Müller DT; Berlth F; Maus MK; Fuchs C; Dübbers M; Schröder W; Bruns CJ; Leers JM
    Dis Esophagus; 2018 Oct; 31(10):. PubMed ID: 29534167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wireless oesophageal pH monitoring: establishing values in a multiracial cohort of asymptomatic Asian subjects.
    Ang D; Xu Y; Ang TL; Law NM; Poh CH; Teo EK; Fock KM
    Dig Liver Dis; 2013 May; 45(5):371-6. PubMed ID: 23287012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of prolonged pH measurements on the diagnosis of gastroesophageal reflux disease: 4-day wireless pH studies.
    Scarpulla G; Camilleri S; Galante P; Manganaro M; Fox M
    Am J Gastroenterol; 2007 Dec; 102(12):2642-7. PubMed ID: 17850412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel placement method of the Bravo wireless pH monitoring capsule for measuring intragastric pH.
    Chang JH; Choi MG; Yim DS; Cho YK; Park JM; Lee IS; Kim SW; Chung IS
    Dig Dis Sci; 2009 Mar; 54(3):578-85. PubMed ID: 18649136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.